1. Home
  2. TCRX vs LUD Comparison

TCRX vs LUD Comparison

Compare TCRX & LUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • LUD
  • Stock Information
  • Founded
  • TCRX 2018
  • LUD 2004
  • Country
  • TCRX United States
  • LUD Hong Kong
  • Employees
  • TCRX N/A
  • LUD N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • LUD
  • Sector
  • TCRX Health Care
  • LUD
  • Exchange
  • TCRX Nasdaq
  • LUD NYSE
  • Market Cap
  • TCRX 90.5M
  • LUD 96.7M
  • IPO Year
  • TCRX 2021
  • LUD 2025
  • Fundamental
  • Price
  • TCRX $1.27
  • LUD $4.00
  • Analyst Decision
  • TCRX Strong Buy
  • LUD
  • Analyst Count
  • TCRX 7
  • LUD 0
  • Target Price
  • TCRX $9.86
  • LUD N/A
  • AVG Volume (30 Days)
  • TCRX 389.5K
  • LUD 9.5K
  • Earning Date
  • TCRX 05-06-2025
  • LUD 01-01-0001
  • Dividend Yield
  • TCRX N/A
  • LUD N/A
  • EPS Growth
  • TCRX N/A
  • LUD N/A
  • EPS
  • TCRX N/A
  • LUD N/A
  • Revenue
  • TCRX $4,421,000.00
  • LUD $44,863,430.00
  • Revenue This Year
  • TCRX $47.30
  • LUD N/A
  • Revenue Next Year
  • TCRX $74.30
  • LUD N/A
  • P/E Ratio
  • TCRX N/A
  • LUD N/A
  • Revenue Growth
  • TCRX N/A
  • LUD N/A
  • 52 Week Low
  • TCRX $1.02
  • LUD $3.40
  • 52 Week High
  • TCRX $9.69
  • LUD $5.43
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 37.62
  • LUD N/A
  • Support Level
  • TCRX $1.32
  • LUD N/A
  • Resistance Level
  • TCRX $1.65
  • LUD N/A
  • Average True Range (ATR)
  • TCRX 0.12
  • LUD 0.00
  • MACD
  • TCRX -0.02
  • LUD 0.00
  • Stochastic Oscillator
  • TCRX 0.00
  • LUD 0.00

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About LUD LUDA TECHNOLOGY GROUP LIMITED

Luda Technology Group Ltd is a company that is principally engaged in the manufacture and sale of stainless steel and carbon steel flanges and fittings products and trading of steel pipes, valves, and other steel tubing products.

Share on Social Networks: